No quarterly revenue total was found in AVAI BIO, INC.'s SEC filings.
Avai Bio, Inc. (AVAI) files with the SEC under industry code 7374, Services-Computer Processing & Data Preparation.
Revenue
—
Net income
$-552,041
-213.2% vs year-ago quarter
Operating cash flow
$-414,258
-72.4% vs year-ago quarter
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
153.92M
+11.8% vs year-ago quarter
Net cash
$-1,773
Q4 FY2026
Operating margin
—
Company profile
- Industry
- Services-Computer Processing & Data Preparation (SIC 7374)
- Listed as
- AVAI (OTC)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- Las Vegas, NV
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1740797
- Former names
- AVANT TECHNOLOGIES INC. (until Feb 9, 2026); TREND INNOVATIONS HOLDING INC. (until Jul 19, 2023); FREECOOK (until Jun 5, 2020)
Other Services-Computer Processing & Data Preparation companies
- Automatic Data Processing Inc ADP
- Workday, Inc. WDAY
- Verisk Analytics, Inc. VRSK
- Toast, Inc. TOST
- Reddit, Inc. RDDT
- Hinge Health, Inc. HNGE
- RingCentral, Inc. RNG
- Pegasystems Inc PEGA
All 110 Services-Computer Processing & Data Preparation companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2027 Jun 30, 2026 |
Q3 FY2026 Dec 31, 2025 |
Q2 FY2026 Sep 30, 2025 |
Q1 FY2026 Jun 30, 2025 |
Q4 FY2025 Mar 31, 2025 |
|---|---|---|---|---|---|
| Operating income | -$552,041 | -$553,727 | -$453,016 | $487,589 | — |
| Net income | -$552,041 | -$553,727 | -$453,016 | $487,589 | $464,072 |
| Operating cash flow | -$414,258 | -$347,127 | -$371,547 | -$240,343 | -$187,500 |
| Total assets | $791,750 | $172,912 | $231,372 | $145,306 | $224,745 |
| Total liabilities | $4.0M | $3.0M | $2.5M | $2.1M | $1.8M |
| Stockholders' equity | -$3.2M | -$2.8M | -$2.3M | -$2.0M | -$1.6M |
| Cash and investments | $83,586 | $50,402 | $91,995 | $10,062 | $81,053 |
| Total debt | — | $124,590 | $124,590 | $127,983 | $112,520 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 10-K | Annual report | Jul 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
May 8, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | Feb 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Feb 9, 2026 | Feb 3, 2026 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
All 117 Avai Bio, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.